Back to mobile site

UPDATE: Goldman Sachs Starts Reata Pharmaceuticals (RETA) at Buy

May 24, 2021 2:55 AM EDT Send to a Friend
(Updated - May 24, 2021 4:24 AM EDT)

Goldman Sachs analyst Salveen Richter initiates coverage on Reata Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login